Syndrome News and Research

RSS

Overcoming cancer relapse with CAR-Enhancer therapy

Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant limitation: many patients, including those whose cancer goes into full remission, eventually relapse. In a new study, Dana-Farber Cancer Institute researchers report on a technique with the potential to eliminate that problem.

26 Jul 2024

COVID pandemic accelerated brain aging, especially in males and deprived groups

The COVID-19 pandemic accelerated brain aging, particularly in males and those from deprived backgrounds, with significant cognitive performance decline in infected individuals. This impact was observed regardless of COVID-19 infection status, highlighting the role of psychosocial stressors.

25 Jul 2024

Experimental cancer drug could make thinking easier for individuals with Rett syndrome

An experimental cancer drug could make thinking easier for individuals with Rett syndrome, a rare disorder linked to autism, according to new research from the University of California San Diego -; a discovery that could lead to therapies for patients with other neurological conditions.

25 Jul 2024

Study reveals moderate burden of post-COVID conditions in primary care

The post-COVID-19 conditions (PCC) or long COVID prevalence among United States (US) adults infected with SARS-CoV-2.

25 Jul 2024

Study highlights infection as major post-CAR-T therapy challenge

In patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL), the two hallmark post-chimeric antigen receptor (CAR)-T therapy toxicities are extremely rare after two weeks, supporting a shorter, more flexible toxicity monitoring period, according to a study published in Blood Advances.

25 Jul 2024

Cognitive decline persists in older adults long after severe COVID-19 recovery

Older adults recovering from COVID-19 experience varying degrees of cognitive decline over 2.5 years, with severe cases showing the most significant impact. Early cognitive care and monitoring are crucial for improving outcomes.

24 Jul 2024

How indoor microbiomes shape our health and well-being

Indoor microbiomes, influenced by urbanization and building design, significantly impact human immune, neurological, and endocrine health. This research emphasizes the need for innovative approaches to harness these microbial ecosystems for improved public health outcomes.

24 Jul 2024

New study sheds light on irregular heartbeat risk

Two new, basic animal research studies shed light on alcohol consumption and the heart. The first study may help explain why binge drinking sometimes causes an irregular heartbeat and a possible way to prevent it. The second study investigated why alcohol may have a negative impact on heart function in women taking estrogen replacement therapy.

23 Jul 2024

Study finds no direct link between pandemic social distancing and neonatal mortality

A recent study in JAMA Network Open found no significant link between social distancing during the COVID-19 pandemic and overall neonatal mortality rates in the U.S., though a two-month lag indicated some increase in early neonatal deaths and preterm births.

23 Jul 2024

Study: GI conditions tied to intracranial aneurysm development and rupture

There is a potential connection between a diagnosis of certain gastrointestinal (GI) syndromes and the formation and rupture of intracranial (brain) aneurysms, according to research presented today at the Society of NeuroInterventional Surgery's (SNIS) 21st Annual Meeting.

22 Jul 2024

Understanding the new coronavirus mutant strain KP.3.1.1

Researchers in Japan evaluated the SARS-CoV-2 KP.3.1.1 variant, finding it has higher transmissibility and immune evasion compared to previous variants, posing new challenges for public health measures.

22 Jul 2024

Long-term immune changes persist in unvaccinated COVID-19 patients

Study reveals that unvaccinated individuals experience significant long-term changes in immune parameters up to ten months post-COVID-19 infection, with a shift towards a Th2 cytokine profile.

21 Jul 2024

Saffron: A golden remedy for modern health challenges

Review highlights saffron's potential in preventing and treating various human diseases through its bioactive compounds. Clinical and preclinical studies confirm saffron's benefits in conditions like maculopathy, depression, neurodegenerative diseases, and cancer.

21 Jul 2024